Evidence map›Paper›PMID 31829559›Full record

ArticleBiochemistry2019

Nonspecific Binding of RNA to PARP1 and PARP2 Does Not Lead to Catalytic Activation.

Meagan Y Nakamoto, Johannes Rudolph, Deborah S Wuttke, Karolin Luger

Abstract read
In one paragraph

Article in Biochemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. PARP1 Exhibits an Enzymatically Inactive Chromatin Binding Mode.bioRxiv : the preprint server for biology · 2026
    Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. The multifaceted role of PARP1 in RNA biogenesis.Wiley interdisciplinary reviews. RNA · 2021
    Review
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Meagan Y NakamotoDepartment of Biochemistry , University of Colorado, Boulder , Boulder , Colorado 80309 , United States.
Johannes RudolphDepartment of Biochemistry , University of Colorado, Boulder , Boulder , Colorado 80309 , United States.ORCID 0000-0003-0230-3323
Deborah S WuttkeDepartment of Biochemistry , University of Colorado, Boulder , Boulder , Colorado 80309 , United States.ORCID 0000-0002-8158-8795
Karolin LugerDepartment of Biochemistry , University of Colorado, Boulder , Boulder , Colorado 80309 , United States.

Funding

Structure and Mechanism of Chromatin-Bound PARP1R01CA218255 · NCI · UNIVERSITY OF COLORADO · PI Karolin Luger · 2017 to 2026
$4.5M
Predoctoral Training Molecular BiophysicsT32GM065103 · NIGMS · UNIVERSITY OF COLORADO AT BOULDER · PI FALKE, JOSEPH J · 2002 to 2021
$4.3M
RNA Regulation of Transcription Factor ActivityR01GM120347 · NIGMS · UNIVERSITY OF COLORADO · PI WUTTKE, DEBORAH S. · 2016 to 2024
$3.2M
Howard Hughes Medical InstituteNCI NIH HHS R01 CA218255NIGMS NIH HHS R01 GM120347NIGMS NIH HHS T32 GM065103
6 · The paper itself

Abstract

Poly(ADP-ribose) polymerases 1 and 2 (PARP1 and PARP2, respectively), upon binding damaged DNA, become activated to add long chains of poly(ADP-ribose) (PAR) to themselves and other nuclear proteins. This activation is an essential part of the DNA damage response. The PAR modifications recruit the DNA repair machinery to sites of DNA damage and result in base excision and single-strand break repair, homologous recombination, nucleotide excision repair, and alternative nonhomologous end joining. More recently, both PARP1 and PARP2 have been shown to bind to or be activated by RNA, a property that could interfere with the function of PARP1 and PARP2 in the response to DNA damage or lead to necrosis by depletion of cellular NAD

Indexed as

Models, MolecularPoly (ADP-Ribose) Polymerase-1Protein BindingProtein DomainsRNAPoly (ADP-Ribose) Polymerase-1RNA

Identifiers

PMID31829559
PMCPMC7386247

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.